Wednesday, January 18, 2012

Gilead hires Roy Baynes to lead oncology unit

Gilead Sciences Inc. said Wednesday it has hired Dr. Roy Baynes as its senior vice president, oncology therapeutics.
The Foster City-based biopharmaceutical company (NASDAQ:GILD) said Baynes is expected to report to Norbert Bischofberger, executive vice president, R&D and chief scientific officer, in his new role.

No comments:

Post a Comment